Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling emergency radiology demand for FIFA 2026 and the Los Angeles 2028 Olympic Games using discrete-event simulation.

Emergency radiology·2026
Same author

Hantavirus infection in emergency radiology: Imaging manifestations, pathophysiology, and infection control considerations.

Emergency radiology·2026
Same author

Radiology Preparedness for the 2026 FIFA World Cup and the Los Angeles 2028 Olympic Games: Lessons From Previous Major Sporting Events.

Journal of the American College of Radiology : JACR·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In Vivo.

bioRxiv : the preprint server for biology·2026
Same author

Reducing time to arteriovenous access creation in incident end stage kidney disease: A single-centre quality improvement study.

The journal of vascular access·2026

Related Experiment Video

Updated: Jul 5, 2026

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

Prioritizing hits from phenotypic high-content screens.

Jonathan Low1, Louis Stancato, Jonathan Lee

  • 1Department of Cancer Growth and Translational Genetics, Eli Lilly & Co, Indianapolis, IN 46285, USA.

Current Opinion in Drug Discovery & Development
|April 23, 2008
PubMed
Summary
This summary is machine-generated.

High-content screening (HCS) generates complex data, but new analysis methods combined with other techniques are unlocking its potential for drug discovery. These integrated approaches accelerate the identification of new therapeutic agents.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Related Experiment Videos

Last Updated: Jul 5, 2026

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • High-content screening (HCS) has emerged as a powerful tool for observing treatment effects across multiple experimental parameters.
  • HCS generates large, complex datasets requiring sophisticated analysis techniques.
  • Advances in computational analysis are crucial for fully leveraging HCS data.

Purpose of the Study:

  • To review how integrated technologies are driving the drug discovery process.
  • To illustrate the successful application of multi-parametric HCS data analysis in drug discovery.
  • To highlight the synergy between HCS, RNA interference, and biochemical methods.

Main Methods:

  • Utilizing advanced computational approaches for analyzing multi-parametric HCS data.
  • Integrating HCS with RNA interference (RNAi) for target validation.
  • Combining HCS with target-based biochemistry and structural analysis.
  • Employing high-content screening for comprehensive experimental parameter observation.

Main Results:

  • Demonstrated successful application of integrated technologies in advancing drug discovery pipelines.
  • Showcased how complete analysis of multi-parametric HCS data unlocks screening potential.
  • Illustrated the synergistic effect of combining HCS with other molecular biology techniques.

Conclusions:

  • The combination of advanced HCS data analysis with complementary techniques significantly aids drug discovery.
  • Integrated approaches are essential for fully realizing the potential of high-content screening.
  • This synergistic strategy accelerates the identification and development of novel therapeutics.